MassChallenge Startups Create Impact

2,928

Startups Accelerated

$8.6B

Funding Raised

$3.6B

Revenue Generated

186K+

Jobs Created

Our startups

Be inspired. Search our startups.

Clear  
Intragel Therapeutics

30% of cancer patients are unfit for systemic chemotherapy treatment, which is a pillar in the fight against cancer, due to it's toxicity. Intragel invented a ready to use pre-filled syringe with honey-like gel mixed with chemo-drug that can be injected into the tumors where it settles, due to it's hydrophobic nature, and start disintegrating slowly over two months, releasing the drug safely and constantly. Thus replacing the toxic 5-8 chemotherapy coursed with single safe injection of TumoCure
Safe, Effective and Targeted Anti-Cancer Therapeutics For Solid Tumor Oncology Patients.

Connect with Intragel Therapeutics

Intragel Therapeutics

2022

2022 Finalist IL-121

Sub industry

Therapeutics (Pharma / Biotech)

Mission

Our mission is to equip bold entrepreneurs to disrupt the status quo and to create meaningful change.